The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

Amendment of regulation 345

This section has no associated Explanatory Memorandum

29.  In regulation 345(1) (immunity from civil liability), in paragraph (3)—

(a)after sub-paragraph (a) insert—

(aa)if there is no holder of an authorisation for the product but the sale or supply of the product is authorised by the licensing authority on a temporary basis under regulation 174, the person responsible for placing the product on the market in the United Kingdom;;

(b)in sub-paragraph (c), for “paragraph (a) or (b); or” substitute “sub-paragraph (a), (aa) or (b);”;

(c)insert “; or” at the end of sub-paragraph (d); and

(d)after sub-paragraph (d) insert—

(e)any person, not being a health care professional, who administers the product in accordance with a protocol of the type mentioned in regulation 247A..

(1)

Regulation 345 has been amended by S.I. 2019/775.